Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Video-Assisted Thoracoscopic Surgery
98%
Epithelioma
86%
Segmentectomy
86%
Epidermal Growth Factor Receptor
83%
Epidermal Growth Factor Receptor Kinase Inhibitor
82%
Overall Survival
60%
Progression Free Survival
53%
Computer Assisted Tomography
53%
Mediastinal Tumor
52%
Thymus Cancer
47%
Hazard Ratio
46%
Lymphocyte
43%
Combination Therapy
40%
Prognostic Factor
36%
Lung Tumor
34%
Pneumonectomy
34%
Radiomics
34%
Lung Cancer
33%
Thymic Carcinoma
30%
Neutrophil
26%
Lobectomy
23%
Surgical Technique
20%
Recurrent Disease
19%
Forced Expiratory Volume
19%
Esophageal Cancer
19%
Lung Adenocarcinoma
19%
Lung Function
19%
Primary Tumor
19%
Cancer Surgery
18%
Health Care Cost
18%
Metastasectomy
17%
Division
17%
Pulmonary Sequestration
17%
Cohort Analysis
17%
Programmed Death 1 Ligand 1
17%
Tumor Ablation
17%
Oncology
17%
Transthoracic Biopsy
17%
Programmed Cell Death
17%
Retrospective Cohort Study
17%
Learning Curve
17%
Multiple Pulmonary Nodules
17%
Magnetic Resonance Imaging of Brain
17%
Postoperative Recovery
17%
Neoadjuvant Immunotherapy
17%
Incision
17%
Quality of Life
17%
Lifespan
17%
Osimertinib
17%
Keyphrases
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
53%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
51%
Overall Survival
41%
Hazard Ratio
40%
EGFR mutation
36%
Combination Therapy
36%
Mediastinal Tumor
34%
Non-small Cell Lung Cancer (NSCLC)
34%
Progression-free Survival
29%
Neutrophil-to-lymphocyte Ratio
26%
Monotherapy
25%
Survival Benefit
24%
Epidermal Growth Factor Receptor
23%
Tertiary Care Hospital
22%
Confidence Interval
19%
Non-small Cell Lung Cancer Patients
19%
Prognostic Factors
18%
Masaoka Stage
18%
Complex Segmentectomy
17%
Propensity Matching Analysis
17%
Convolutional Neural Network
17%
Life Cost
17%
Prognosis Analysis
17%
Pulmonary Metastasectomy
17%
Deep Learning Radiomics
17%
Tumor Resection
17%
Neural Network Analysis
17%
Multi-institutional Study
17%
Lung Nodule Detection
17%
Programmed Death-ligand 1 Expression
17%
Surgical Resection
17%
Propensity Score Analysis
17%
Channel-spatial Attention
17%
False Positive Reduction
17%
NnU-Net
17%
Taiwan
17%
Lung Nodule Segmentation
17%
Unified Focal Loss
17%
Transthoracic Needle Biopsy
17%
Puncture Accuracy
17%
EGFR-mutant Lung Cancer
17%
Improved Survival
17%
Video-assisted Thoracoscopic Surgery
17%
Adenocarcinoma
17%
Thymic Epithelial Tumors
17%
Completely Resected
17%
Volume Fraction Estimation
17%
Chemoimmunotherapy
17%
Spatial Attention Model
17%
Chest CT
17%
